跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
复方氨酚烷胺片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Paracetamol and Amantadine Hydrochloride Tablets
Approved
化学药品
Compound Paracetamol and Amantadine Hydrochloride Tablets
天昌元医药(吉林)股份有限公司
🇨🇳 National Medical Products Administration
Approval Date
Aug 10, 2020
Approval ID
7Leaex9PYAA
Company
天昌元医药(吉林)股份有限公司
Type
化学药品
Approval Details
Approval Id
7Leaex9PYAA
Approval Number
国药准字H22025357
Generic Name
复方氨酚烷胺片
Generic Name En
Compound Paracetamol and Amantadine Hydrochloride Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
复方
Reg Date
2020-08-10
Company Name
天昌元医药(吉林)股份有限公司
Company Address
东丰县三合工业园区
Production Company Name
天昌元医药(吉林)股份有限公司
Production Company Address
东丰县三合工业园区
Company Detail Path
/organization/tian-chang-yuan-yi-yao-ji-lin-gu-fen-you-xian-gong-si
Production Company Detail Path
/organization/tian-chang-yuan-yi-yao-ji-lin-gu-fen-you-xian-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 10, 2020
Approval ID
7Leaex9PYAA
Type
化学药品
Back to NMPA Approvals